Recently, the complete sequencing of 7416 [4] and 1220 [5] human cancer genomes revealed the deregulation of IRS-4 gene in cancer cells; furthermore, the data situate IRS-4 in a tumor growth-promoting role [4]. This evidence concerns the gene IRS4 and cancer.